The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing AM Wojtowicz, S Oliveira, MW Carlson, A Zawadzka, CF Rousseau, ... Wound repair and regeneration 22 (2), 246-255, 2014 | 245 | 2014 |
The need for a public proteomics repository JT Prince, MW Carlson, R Wang, P Lu, EM Marcotte Nature biotechnology 22 (4), 471-472, 2004 | 212 | 2004 |
Three‐dimensional tissue models of normal and diseased skin MW Carlson, A Alt‐Holland, C Egles, JA Garlick Current Protocols in Cell Biology 41 (1), 19.9. 1-19.9. 17, 2008 | 180 | 2008 |
A map of human protein interactions derived from co‐expression of human mRNAs and their orthologs AK Ramani, Z Li, GT Hart, MW Carlson, DR Boutz, EM Marcotte Molecular systems biology 4 (1), 180, 2008 | 101 | 2008 |
Drug-induced inhibition of the peripheral-type benzodiazepine receptor expression and cell proliferation in human breast cancer cells. V Papadopoulos, A Kapsis, H Li, H Amri, M Hardwick, M Culty, ... Anticancer research 20 (5A), 2835-2847, 2000 | 93 | 2000 |
Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents Y Shamis, KJ Hewitt, MW Carlson, M Margvelashvilli, S Dong, CK Kuo, ... Stem cell research & therapy 2, 1-12, 2011 | 83 | 2011 |
Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells KJ Hewitt, Y Shamis, RB Hayman, M Margvelashvili, S Dong, MW Carlson, ... PLoS one 6 (2), e17128, 2011 | 80 | 2011 |
Three-dimensional epithelial tissues generated from human embryonic stem cells KJ Hewitt, Y Shamis, MW Carlson, E Aberdam, D Aberdam, JA Garlick Tissue Engineering Part A 15 (11), 3417-3426, 2009 | 67 | 2009 |
Chronic ulcerative stomatitis: evidence of autoimmune pathogenesis MW Carlson, JA Garlick, LW Solomon Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2011 | 41 | 2011 |
Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways MW Carlson, VR Iyer, EM Marcotte BMC genomics 8, 1-13, 2007 | 40 | 2007 |
Epidermal Stem Cells Are Preserved During Commercial-Scale Manufacture of a Bilayered, Living Cellular Construct (Apligraf®) M Carlson, K Faria, Y Shamis, J Leman, V Ronfard, J Garlick Tissue Engineering Part A 17 (3-4), 487-493, 2011 | 28 | 2011 |
BIM-44058, a novel analog of PTHrP with enhanced bone building activity, but decreased calcium-mobilization potential MD Culler, J Dong, Y Shen, J Taylor, L Carlile, T Sullican J Bone Miner Res 16 (Suppl 1), M460, 2001 | 25 | 2001 |
The dual topoisomerase inhibitor, BN 80927, is highly potent against cell proliferation and tumor growth M Huchet, D Demarquay, H Coulomb, P Kasprzyk, M Carlson, J Lauer, ... Annals of the New York Academy of Sciences 922 (1), 303-305, 2000 | 21 | 2000 |
Abstract ND09: The discovery and characterization of CFT8634: A potent and selective degrader of BRD9 for the treatment of SMARCB1-perturbed cancers KL Jackson, RV Agafonov, MW Carlson, P Chaturvedi, D Cocozziello, ... Cancer Research 82 (12_Supplement), ND09-ND09, 2022 | 20 | 2022 |
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents AM Liberatore, H Coulomb, D Pons, O Dutruel, PG Kasprzyk, M Carlson, ... Molecular cancer therapeutics 7 (8), 2426-2434, 2008 | 18 | 2008 |
Monoclonal microbial EDP1503 to induce antitumor responses via gut-mediated activation of both innate and adaptive immunity HA Gardner, S Kashyap, H Ponichtera, P Sandy, P Parameswaran, ... J Clin Oncol 37 (15_suppl), e14241-e14241, 2019 | 10 | 2019 |
Development of an AchillesTAG degradation system and its application to control CAR-T activity GK Veits, CS Henderson, A Vogelaar, SJ Eron, L Lee, A Hart, RW Deibler, ... Current Research in Chemical Biology 1, 100010, 2021 | 9 | 2021 |
P-325 Oral delivery of a single microbial strain, EDP1503, induces anti-tumor responses via gut-mediated activation of both innate and adaptive immunity D McHale, L Francisco-Anderson, P Sandy, S Shariffudin, M Goldberg, ... Annals of Oncology 31, S195, 2020 | 9 | 2020 |
An E-ring modified camptothecin, BN 80915, shows unusual stability and high activity both in vitro and in vivo PG Kasprzyk, D Demarquay, L Lesueru-Ginot, M Carlson, J Lauer, ... Proc AACR 40, 739, 1999 | 7 | 1999 |
Abstract PS11-27: a phase I/II clinical trial of EDP1503 with pembrolizumab for triple-negative breast cancer L Francisco-Anderson, S Shariffudin, H Gardner, P Sandy, M Goldberg, ... Cancer Research 81 (4_Supplement), PS11-27-PS11-27, 2021 | 6 | 2021 |